Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HO-1 Expression and Influenza Vaccine Response in Sickle Cell Disease
NCT03111589Completed
- Start
- Oct 2016
- Primary completion
- Oct 2018
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of influenza A (H1N1) 2009 monovalent vaccine in influenza (4 arms). Primary endpoints: Intracellular HO-1 expression in monocytes, HO-1 level in serum and 3 more. Started Oct 2016; status: completed.
02
Drugs
influenza A (H1N1) 2009 monovalent vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03111589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03111589.